About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Los Angeles | 52 Studies

Clinical Trials Brain CancerLos Angeles

Brain Cancer Clinical Trials in Los Angeles

Find 52 clinical trials for brain cancer near Los Angeles, California. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 52 trials

TerminatedA Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaThe objective of this study is to evaluate the response of subjects with recurrent glioblastoma to continuous therapy of PLX3397.NCT01349036·Los Angeles, California and 5 others TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsThis phase I trial studies the side effects and best dose of palbociclib isethionate in treating younger patients with central nervous system tumors that have grown, come back, or…NCT02255461·Los Angeles, California and 10 others

Brain Cancer Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedRadiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00304031·Fairbanks, Alaska and 350 others

RecruitingBiologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma CellsThe purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors.NCT06059690·Los Angeles, California

CompletedErlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaPhase I/II trial to study the effectiveness of erlotinib in treating patients who have recurrent malignant glioma or recurrent or progressive meningioma.NCT00045110·Los Angeles, California and 6 others

CompletedTesting Ramipril to Prevent Memory Loss in People With GlioblastomaThis study is to determine if an oral drug called Ramipril can lower the chance of memory loss in patients with glioblastoma getting chemoradiation.NCT03475186·Anchorage, Alaska and 422 others

CompletedTemozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006024·Birmingham, Alabama and 234 others

CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die.NCT00002545·Birmingham, Alabama and 259 others

CompletedA Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaThe purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can…NCT01498328·Birmingham, Alabama and 44 others

UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerThe primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.NCT00045968·Birmingham, Alabama and 85 others

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

CompletedBevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsThis partially randomized phase II trial with a safety run-in component studies the side effects and how well bevacizumab given with or without trebananib works in treating…NCT01609790·Anchorage, Alaska and 243 others

CompletedDendritic Cell Vaccine for Patients With Brain TumorsThe main purpose of this study is to evaluate the most effective immunotherapy vaccine components in patients with malignant glioma.NCT01204684·Los Angeles, California

CompletedA Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationThis study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs…NCT02573324·Phoenix, Arizona and 211 others

CompletedPhase II Study of BKM120 for Subjects With Recurrent GlioblastomaBKM120 is a newly discovered drug that has been used in other research studies.NCT01339052·Los Angeles, California and 6 others

CompletedAflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaThis phase I trial is studying the side effects and best dose of aflibercept when given together with radiation therapy and temozolomide in treating patients with newly diagnosed…NCT00650923·Los Angeles, California and 8 others

CompletedA Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaThe study's purpose is to see if the drug, abemaciclib, is safe and effective when given with other drugs to kill cancer cells.NCT04238819·Phoenix, Arizona and 24 others

CompletedCellular Immunotherapy Study for Brain CancerThe purpose of this research study to determine if treating recurrent malignant gliomas with another person's (donor) immune system cells known as aCTL cells, will be safe.NCT01144247·Los Angeles, California

TerminatedA Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511This is a multicenter, open-label, continuation study to allow subjects who have previously received Toca 511 to continue to receive Toca FC and to allow for extended safety…NCT04327011·Los Angeles, California and 10 others

TerminatedImetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsThis molecular biology and phase II trial studies how well imetelstat sodium works in treating younger patients with recurrent or refractory brain tumors.NCT01836549·Los Angeles, California and 10 others

Page 1 of 3Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia